Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1061 | 885 | 1061 | 1258 | 1925 | - |
Fund Return | 6.06% | -11.55% | 6.06% | 7.95% | 13.99% | - |
Place in category | 10 | 178 | 10 | 6 | 5 | - |
% in Category | 6 | 87 | 6 | 2 | 3 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S Horizon Global Technology FundA1u | 612.15M | 32.70 | 8.98 | 16.06 | ||
S Horizon Global Technology Fund Au | 2.53B | 32.70 | 8.98 | 16.06 | ||
S Horizon Global Technology Fund G2 | 334.63M | 34.28 | 10.16 | 17.26 | ||
S Horizon Global Technology Fund 1u | 16.5M | 33.90 | 9.94 | 17.07 | ||
S Horizon Global Technology Fund Iu | 442.54M | 33.90 | 9.94 | 17.08 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Franklin Biotech Discovery Nacc | 99.59M | 9.10 | 3.31 | 2.36 | ||
LU0133359157 | 1.38B | 2.18 | 2.28 | 4.73 | ||
Equities L Biotechnology Class I US | 1.38B | 2.92 | 2.58 | 5.59 | ||
Equities L Biotechnology Class R US | 1.38B | 3.48 | 3.56 | 6.05 | ||
Candriam Equities Biotech C USD Cap | 1.38B | 2.56 | 2.68 | 5.20 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 6.98 | 461.68 | +5.31% | |
argenx ADR | US04016X1019 | 4.96 | 655.13 | -1.58% | |
Amgen | US0311621009 | 4.90 | 285.42 | +0.49% | |
Sarepta | US8036071004 | 4.14 | 113.72 | -0.64% | |
Ascendis Pharma AS | US04351P1012 | 4.03 | 130.66 | +2.64% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Sell | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review